{"id":386874,"date":"2020-11-23T09:18:27","date_gmt":"2020-11-23T14:18:27","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=386874"},"modified":"2020-11-23T09:18:27","modified_gmt":"2020-11-23T14:18:27","slug":"adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/","title":{"rendered":"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">EMERYVILLE, Calif., Nov.  23, 2020  (GLOBE NEWSWIRE) &#8212; Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the appointment of Spyros Papapetropoulos, MD, PhD, to its Board of Directors. Spyros brings more than 20 years of academic and industry experience with a focus on neurology, and previously held R&amp;D and scientific leadership roles at Acadia, Cavion, Teva, Pfizer, Allergan, and Biogen. Additionally, Adamas announced the retirement of Ivan Lieberburg, MD, PhD from the Adamas board.<\/p>\n<p align=\"justify\">\u201cI would like to sincerely thank Ivan for his dedicated service to Adamas since 2004. He played a critical role through multiple successful NDA submissions and our evolution into a successful commercial organization. We wish him well,\u201d said David L. Mahoney, Chairman, Adamas. \u201cWe are pleased to have Spyros join us at this next stage of growth. As a seasoned research and development leader, he will be an outstanding addition to our board.\u201d<\/p>\n<p align=\"justify\">\u201cSpyros\u2019 extensive experience within neurodegenerative diseases and movement disorders, along with his track record of bringing meaningful therapies to market ideally position him to bring an important perspective to the board. I look forward to his contributions as we continue to deliver on our mission for patients and unlock shareholder value,\u201d added Neil F. McFarlane, CEO.<\/p>\n<p align=\"justify\">\u201cI am delighted to join Adamas at this exciting time in the journey towards being a leading neurology company,\u201d said Spyros Papapetropoulos. \u201cI very much look forward to being part of the company\u2019s future growth and continued success.\u201d<\/p>\n<p align=\"justify\">Throughout his career, Spyros has led multiple pharmaceutical development programs resulting in successful regulatory filings and product launches. Spyros is a board-certified Neurologist trained in London, UK, and has authored more than 160 peer-reviewed publications. Additionally, Spyros has served on various U.S. government and non-profit committees on healthcare and biomedical research innovation.<\/p>\n<p align=\"justify\">\n        <strong>About Adamas<\/strong><br \/>\n        <br \/>At Adamas, our vision is clear \u2013 to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers, and society. We are a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=n6EwRJTsGhq4kAwbHUjn7Z78D-gCtLMYBvSgm_3nWLWYv_V8S2gKM6_D8v01cML9p9UM6nCbCFWwIY5f3gHwGZll6Uygi2VrxBOwG8w7YdM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.adamaspharma.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Contact:<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Media:<\/strong><br \/>\n        <br \/>Sarah Mathieson<br \/>Vice President, Corporate Communications<br \/>510-450-3528<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ut1O4y1Gdp7E3SJGjyhfbJilZ7NnB7apOdq7Kypi0okdHEDethAA1RrghMk7RWvfd8e8OG7sC5GPfSteTrOBw2i7zeQfYNca8L6L2nLqY0zhy1sx8z0JTaXQZvGqfFlf\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">smathieson@adamaspharma.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Investors:<\/strong><br \/>\n        <br \/>Peter Vozzo<br \/>Managing Director, Westwicke<br \/>443-213-0505<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zMJ_MUw6usKexEP2tszERdsZgFgkj60c5DBNtk83HcMGK1b5lUiDLj3DsZZ3jac-dJKEJ9-683EyZGtjWdajOWU_EiUypcRSM5YUQQHV6xM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">peter.vozzo@westwicke.com<\/a>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/e00fdb8e-74a0-4b59-a106-0f13aaf7ae64\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>EMERYVILLE, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) &#8212; Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the appointment of Spyros Papapetropoulos, MD, PhD, to its Board of Directors. Spyros brings more than 20 years of academic and industry experience with a focus on neurology, and previously held R&amp;D and scientific leadership roles at Acadia, Cavion, Teva, Pfizer, Allergan, and Biogen. Additionally, Adamas announced the retirement of Ivan Lieberburg, MD, PhD from the Adamas board. \u201cI would like to sincerely thank Ivan for his dedicated service to Adamas since 2004. He played a critical role through multiple successful NDA submissions and our evolution &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-386874","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"EMERYVILLE, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) &#8212; Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the appointment of Spyros Papapetropoulos, MD, PhD, to its Board of Directors. Spyros brings more than 20 years of academic and industry experience with a focus on neurology, and previously held R&amp;D and scientific leadership roles at Acadia, Cavion, Teva, Pfizer, Allergan, and Biogen. Additionally, Adamas announced the retirement of Ivan Lieberburg, MD, PhD from the Adamas board. \u201cI would like to sincerely thank Ivan for his dedicated service to Adamas since 2004. He played a critical role through multiple successful NDA submissions and our evolution &hellip; Continue reading &quot;Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-23T14:18:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg\",\"datePublished\":\"2020-11-23T14:18:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/\"},\"wordCount\":405,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/\",\"name\":\"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=\",\"datePublished\":\"2020-11-23T14:18:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/","og_locale":"en_US","og_type":"article","og_title":"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg - Market Newsdesk","og_description":"EMERYVILLE, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) &#8212; Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the appointment of Spyros Papapetropoulos, MD, PhD, to its Board of Directors. Spyros brings more than 20 years of academic and industry experience with a focus on neurology, and previously held R&amp;D and scientific leadership roles at Acadia, Cavion, Teva, Pfizer, Allergan, and Biogen. Additionally, Adamas announced the retirement of Ivan Lieberburg, MD, PhD from the Adamas board. \u201cI would like to sincerely thank Ivan for his dedicated service to Adamas since 2004. He played a critical role through multiple successful NDA submissions and our evolution &hellip; Continue reading \"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-23T14:18:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg","datePublished":"2020-11-23T14:18:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/"},"wordCount":405,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/","name":"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=","datePublished":"2020-11-23T14:18:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDQ2NCMzODM5Mjc1IzIwMDY5NjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/adamas-announces-changes-to-its-board-of-directors-with-the-appointment-of-spyros-papapetropoulos-and-the-retirement-of-ivan-lieberburg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Adamas announces changes to its Board of Directors with the appointment of Spyros Papapetropoulos and the retirement of Ivan Lieberburg"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386874","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=386874"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/386874\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=386874"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=386874"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=386874"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}